Skip to main content
Michael Stang, MD, General Surgery, Durham, NC

MichaelTStangMDFACS

General Surgery Durham, NC

Endocrine, Surgical Oncology (Other than Breast), Minimally Invasive Surgery

Associate Professor, Surgery, Duke University

Dr. Stang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Stang's full profile

Already have an account?

  • Office

    2301 Erwin Rd
    Durham, NC 27710
    Phone+1 919-684-8111

Summary

  • Dr. Michael Stang is a general surgeon in Raleigh, NC and is affiliated with multiple hospitals in the area, including Duke Raleigh Hospital and Duke University Hospital. He received his medical degree from University of Nebraska College of Medicine and has been in practice 17 years. He specializes in endocrine, surgical oncology (other than breast), and minimally invasive surgery and is experienced in hyperthyroidism, toxic thyroid nodule, pheochromocytoma, minimally invasive surgery, and endocrine surgery.

Education & Training

  • UPMC Presbyterian Shadyside
    UPMC Presbyterian ShadysideEndocrine Surgery, 2008 - 2009
  • UPMC Medical Education (Pittsburgh)
    UPMC Medical Education (Pittsburgh)Residency, Surgery, 2000 - 2008
  • University of Nebraska College of Medicine
    University of Nebraska College of MedicineClass of 2000
  • Creighton University
    Creighton UniversityBS, Chemistry and Biology, Summa Cum Laude, 1991 - 1995

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2015 - 2025
  • PA State Medical License
    PA State Medical License 2001 - 2016
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • Paul LoGerfo Research Award American Association of Endocrine Surgeons, 2014
  • Certificate of Excellence in Reviewing European Journal of Surgical Oncology, 2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Robotic Thyroid Surgery  
    Wharry LI, Stang MT, Current Concepts in Surgery, 1/1/2013
  • Robotic Thyroid Surgery: Do it well or don't do it  
    Stang MT, Perrier NP, JAMA Surgery, 1/1/2013
  • Cytoplasmic overexpression of CD95L in esophageal adenocarcinoma cells overcomes resistance to D95-mediated apoptosis  
    Watson GA, Naran S, Zhang X, Stang MT, Queiroz de Oliveira PE, Hughes SJ, Neoplasia, 1/1/2011
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Risk of Cancer in Enlarging Thyroid Nodules is Influenced by the Growth Rate and Cytologic Diagnosis
    Li W, Armstrong M, McCoy K, Stang MT, Ohori P, Kelley ML, Shuai Y, Lebeau SO, Nikiforov YE, Carty SE, Yip L, American Association of Clinical Endocrinologists, Nashville, TN, 1/1/2015
  • Does the Axillary Approach for Robotic Thyroidectomy Affect Subsequent Breast Screening and/or Axillary Staging?
    Chen AW, Hakim C, Gizienski TA, Soran A, Ahrendt GM, Diego EJ, Bonaventura M, Johnson R, Armstrong M, Carty S, Stang M, McGuire KP, McAuliffe PF, Society of Surgical Oncology, Houston, TX, 1/1/2015
  • Heterogeneity and Controversies in Radioactive Iodine Use: are we near a consensus?
    Mon SY, Borrebach JD, Lebeau SO, Coyne C, Carty SE, Yip L, McCoy KL, Stang MT, Ferris RL, Duvvuri U, Joyce J, Tublin M, Nikiforova MN, Nikiforov YE, Hodak SP, The Endocrine Society, Chicago, IL, 1/1/2014
  • Join now to see all

Lectures

  • "Lysosome centered regulation of autophagy in a model of papillary thyroid carcinoma." 
    Nashville, TN - 1/17/2015
  • Does Impotence Improve after Parathyroidectomy in Men with Primary Hyperparathyroidism? 
    Nashville, TN - 1/1/2015
  • Tumor Genotype Determines Phenotype and Disease-Related Outcomes in Thyroid Cancer: A Study of ,510 Patients. 
    San Diego, CA - 1/1/2015
  • Join now to see all

Other

  • The role of PDGF, IGF-, IGF-, TGF-alpha, and EGF as possible autocrine and paracrine factors in the proliferation of human osteosarcoma. (Honors Thesis Research) 
    Michael T. Stang
    Creighton University, Omaha, NE - 1/1/1995

Professional Memberships